 |
|
Evaluation of Efficacy and Complications
Primary Pediatric Orbital Implants After Enucleation
Nancy J. Christmas, MD;
Kurt Van Quill;
Timothy G. Murray, MD;
Craig D. Gordon;
Scott Garonzik;
David Tse, MD;
Thomas Johnson, MD;
Joyce Schiffman, MS;
Joan M. O'Brien, MD
Arch Ophthalmol. 2000;118:503-506.
Background Orbital implants are used routinely in pediatric patients at the time of enucleation. Complications, such as exposure, ptosis, and infection, may occur after implantation. Controversy continues regarding the rate of complications with newer implants in the pediatric population.
Objective To examine the effects of orbital implants on children whose eyes have been enucleated.
Methods Records of orbital implantation after enucleation performed by 5 surgeons on 120 pediatric patients (123 eyes) over a 10.5-year period were reviewed retrospectively. Demographic data, ocular diagnosis, prior ophthalmic surgery, implant characteristics, and postoperative complications were described using a standardized format for all patients, with a minimum of 6 months of follow-up (mean, 3 years).
Results Complications were observed in 7 eyes (5.7%). Implant exposure (1 [0.8%]), implant extrusion (0 [0%]), and implant migration (3 [2.4%]) were rare. One hundred eighteen eyes (96%) had good cosmesis and 120 (98%) had good motility.
Conclusions Orbital implantation after enucleation is successful in the pediatric population. Complications are minimal. Hydroxyapatite implants were not associated with unacceptable complications in this pediatric population.
From the Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla (Drs Christmas, Murray, Tse, and Johnson, Mr Gordon, and Ms Schiffman); Department of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco (Mr Van Quill and Dr O'Brien); and SNG Prosthetic Eye Institute, Boca Raton, Fla (Mr Garonzik). Dr Christmas is a fellow at the Heed Foundation, Cleveland, Ohio, through 2000.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2000;118(4):597.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cyclodiode treatment of neovascular glaucoma secondary to Coats' disease
de Silva and Brookes
Br. J. Ophthalmol. 2007;91:690-691.
FULL TEXT
Magnetically Integrated Microporous Implant: Safety and Efficacy of Secondary Posting
Escalona-Benz et al.
Arch Ophthalmol 2003;121:1596-1600.
ABSTRACT
| FULL TEXT
Design of a Magnetically Integrated Microporous Implant
Murray et al.
Arch Ophthalmol 2000;118:1259-1262.
ABSTRACT
| FULL TEXT
|
